Get the detailed quarterly/annual income statement for Passage Bio, Inc. (PASG). Find out the revenue, expenses and profit or loss over the last fiscal year.

Explore Passage Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PASG.

For PASG, shares are up 24.26% over the past week while the Zacks Medical - Biomedical and Genetics industry is up 3.78% over the same time period.

Passage Bio (PASG) announced new interim results from the first six patients in its Phase 1/2 study for PBGM01 targeted at GM1 Gangliosidosis ((GM1)), Read full story here.

Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Passage Bio (NASDAQ:PASG) traded higher on Thursday after the company announced a series of agreements with GEMMA Biotherapeutics, including a deal to out-license its programs targeting pediatric ...

The current price Passage Bio (PASG) is trading at is $0.32, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch ...